Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Frederic Ullens de Schooten Whettnall, Director. Insider active across 1 company, notably Octopus Biosafety. Cumulatively, 1 reports have been logged. History available since 28 July 2023. The latest transaction was disclosed on 28 July 2023 (Souscription). Regulator: AMF. All data is free.
1 of 1 declaration
Frederic Ullens de Schooten Whettnall is a Board Member at Octopus Biosafety, a company specializing in biotechnology. In his role, he participates in strategic decisions and governance of the company. Frederic brings his expertise in biotechnology and management, contributing to Octopus Biosafety's innovation and performance.